CAMP4

CAMP4 Secures $100 Million Series B Financing to Accelerate Expansion of its Novel Regulatory RNA-Targeting Platform and Advance Lead Programs into the Clinic
Businesswire
Wed, 07/20/22 - 09:36 am
CAMP4
funding
CNS
Dravet syndrome
CAMP4 Therapeutics Receives $30 Million Series A to Continue Developing Unique Discovery Platform
CP Wire
Thu, 05/31/18 - 09:30 am
CAMP4
drug discovery
CAMP4 Therapeutics Receives $30 Million Series A to Continue Developing Unique Discovery Platform
Thu, 05/31/18 - 09:29 am
CAMP4